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Objective: To elucidate the role of integrin a1b1 in chondrocyte responses to inﬂammatory interleukin-
1a (IL-1) and anabolic transforming growth factor-b1 (TGF-b1) in the knee.
Methods: Intracellular calcium transient responses to IL-1 and TGF-b1 were measured in wild type and
integrin a1-null chondrocytes using real time ex vivo confocal microscopy, and immunohistochemistry
was performed to analyze TGF-b1-mediated activation of Smad2/3 in tibial and femoral chondrocytes.
Results: Loss of integrin a1b1 reduces intracellular calcium transient response to IL-1, while it enhances
chondrocyte responses to TGF-b1 as measured by intracellular calcium transients and activation of
downstream Smad2/3.
Conclusions: Integrin a1b1 plays a vital role in mediating chondrocyte responses to two contrasting
factors that are critical players in the onset and progression of osteoarthritis e inﬂammatory IL-1 and
anabolic TGF-b. Further investigation into the molecular mechanisms by which integrin a1b1 mediates
these responses will be an important next step in understanding the inﬂuence of increased expression of
integrin a1b1 during the early stages of osteoarthritis on disease progression.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Chondrocytes maintain articular cartilage by preserving the
balance of catabolic and anabolic activity within the extracellular
matrix1,2. The biological activity of chondrocytes can be mediated
by inﬂammatory and ﬁbrotic factors, an imbalance of which is
implicated in the initiation and progression of osteoarthritis1e5. In
general, inﬂammatory factors such as interleukin-1 (IL-1) promote
the degradation of cartilage while ﬁbrotic factors such as trans-
forming growth factor-b1 (TGF-b) promote anabolic activity2,6e11.
TGF-b also acts to prevent chondrocyte hypertrophy through acti-
vation of the canonical Smad2/3 pathway12,13. In addition to acting
alone, IL-1 and TGF-b can also inﬂuence each other by modulating
TGF-b type II receptor (TbRII) or IL-1 receptor (IL-1R) expression
respectively14e17. The interplay between IL-1 and TGF-b is alsoA.L. Clark, KNB 304, Human
niversity Drive NW, Calgary,
kh), mklorenz@ucalgary.ca
mbra.pozzi@vanderbilt.edu
s Research Society International. Pevident in vivo where TGF-b antagonizes the effects of IL-1 when
injected in combination into young (3months) and old (18months)
mouse knees18.
Integrins are heterodimeric extracellular matrix receptors that
can modulate the activation of growth factor receptors such as
TbRII, IL-1R and epidermal growth factor receptor (EGFR)10,19e27. Of
particular interest to this study is the collagen receptor integrin
a1b1 that binds collagen II and chondron localized collagen VI, and
is found more abundantly in osteoarthritic compared to healthy
cartilage22,28e32. Integrin a1-null mice display no obvious pheno-
typical abnormalities into adulthood, although they develop
spontaneous osteoarthritis earlier in life and more severely than
wild type controls29,33. These results, together with the upregula-
tion of integrin a1b1 in the early stages of disease, suggest that this
receptor offers protection against osteoarthritis29. However the
molecular mechanism(s) through which integrin a1b1 mediates
this safeguard, is yet to be elucidated.
The dynamics (concentration, frequency, timing) of intracellular
calcium ([Ca2þ]i) transients are involved in regulatingmany cellular
processes and an [Ca2þ]i transient is often the ﬁrst measurable
biological response of a cell to external stimuli5,34,35. By using cal-
cium sensitive ﬂuorescent dyes in conjunction with confocalublished by Elsevier Ltd. All rights reserved.
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murine chondrocytes can be determined36. Chondrocyte [Ca2þ]i
transients in response to IL-1 have been previously reported,
however the effects of TGF-b on [Ca2þ]i dynamics are unknown37.
Therefore, the purpose of this study was to compare the his-
tology, morphology and chondrocyte responses to inﬂammatory
IL-1 and anabolic TGF-b in the knees of skeletally mature wild
type and integrin a1-null mice. Ex vivo whole femora assays were
utilized to measure [Ca2þ]i transients and basal activation of
downstream canonical Smad2/3. We hypothesized that although
the knees of integrin a1-null and wild type mice would be his-
tologically and morphologically similar at the tissue level, integrin
a1-null chondrocytes would have heightened responses to IL-1
and suppressed responses to TGF-b, accounting for the earlier
development of spontaneous osteoarthritis in the integrin a1-null
knee.Materials and methods
Animals
All animal procedures were approved by the University of Cal-
gary Animal Care Committee. Breeder pairs of heterozygous
integrin a1-null mice were backcrossed onto the BALB/c back-
ground strain for ten generations33. Homozygous breeder pairs of
integrin a1-null and BALB/c mice were then used to produce the
animals used in this study. Genotype was conﬁrmed by polymerase
chain reaction of ear punch tissue as previously described33. Equal
numbers of male and female skeletally mature BALB/c (wild type)
(age ¼ 21  5 weeks, mass ¼ 27  5 g (mean  sd)) or integrin a1-
null mice (age ¼ 21  3 weeks, mass ¼ 30  4 g (mean  sd)) were
used for this study29,33. Anesthetized mice were euthanized via
cardiac puncture before their hindlimbs were skinned and dis-
located at the hip.Fig. 1. Histological images of a 184-day-old wild type (A and C) and 182 day old integrin a1
and D are magniﬁcations of the boxed areas in A and B respectively). Note that proteoglycan
of chondrocytes are independent of genotype. Frontal (E and F) and sagittal through the med
null (F and H) knee as shown in A and B respectively. Trabecular bone is shaded red, subch
condyles and tibial plateau was rendered transparent to show the analyzed trabecular region
with colors located further right on the spectrum shown below. Trabecular bone architectur
similar between the integrin a1-null and wild type knees.Micro Computed Tomography (microCT) scanning e bone
morphology
Hindlimbs were ﬁxed at a physiological angle in formalin and
high intensity medium resolution (16 mm) microCT scans were
performed on each knee (microCT 35, SCANCO Medical, Wayne,
PA). Regions of interest were contoured and corresponding bone
parameters were evaluated (SCANCOMedical AG,Wayne, PA). Bone
volume and density were evaluated for the calciﬁed menisci, and
the trabecular and subchondral bone of the femur and tibia
[Fig. 1(E) and (F)]36. Subchondral bone thickness was measured
utilizing a circle-drawing algorithm and the mean of ﬁve evenly
spaced thickness measurements taken across the load bearing re-
gion of the knee was reported [Fig. 1(G) and (H)].
Histology
After microCT scanning, the same hindlimbs were dissected free
of muscle and decalciﬁed (CalEX, Fisher Scientiﬁc, Ottawa, ON).
Sagittal sections 8 mm thick were cut through the entire knee (Leica
RM2255) after dehydration and parafﬁn embedding. Sections were
stained with Weigert’s iron hematoxylin (Sigma), 0.2% fast green,
and 0.01% safranin-O using an automated processor (Leica ST5010)
prior to being coverslipped. One section from the center of each
contact regionwas imaged (Zeiss Axiostart plus, AxioCam ICc1) and
histologically graded by three blinded graders using a modiﬁed
Mankin grading scheme38.
Media
All media and reconstitution ingredients were purchased from
Invitrogen, Burlington, ON. Control media (pH 7.41) contained the
following (ﬁnal concentrations): Dulbecco’s Modiﬁed Eagle Me-
dium High Glucose (24 mM D-glucose, no phenol red), L-Glutamine-null (B and D) medial condyle, stained with hematoxylin, fast green, and safranin-O (C
staining intensity, cartilage thickness and surface integrity and the size and abundance
ial condyle (G and H) microCT images of the same wild type (E and G) and integrin a1-
ondral bone blue, and ossiﬁed menisci green in E and F; cortical bone at the femoral
s. Sagittal sections (G and H) shaded with a thickness map with thicker regions shaded
e, subchondral bone thickness, and the size of ossiﬁed menisci and sesamoid bones are
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osmolarity wasmeasured using a freezing point osmometer (Model
3250, Advanced Instruments Inc., Norwood, MA) and adjusted to
300 mOsm by adding sucrose or distilled water.
Interleukin-1a (IL-1) and TGF-b1 (R&D Systems, Burlington, ON)
were reconstituted (10 mg/mL) in phosphate buffered saline (PBS)
or a mixture of 0.1% (w/v) bovine albumin fraction V and 4 mM
hydrochloric acid (HCl(aq)) respectively. These isoforms of IL-1 and
TGF-b were chosen because; (1) they are known to be in the sy-
novial ﬂuid of osteoarthritic patients, (2) IL-1a is more biologically
active in the catabolism of meniscus and cartilage compared to IL-
1b, and (3) TGF-b1 protects against IL-1 induced proteoglycan
degradation3,4,39. Reconstituted treatment or vehicle was diluted in
media to reach ﬁnal treatment or vehicle control concentrations.
Confocal microscopy
Intact femora were isolated using microdissection. Chon-
drocytes were incubated (37  1C) with the calcium sensitive
ﬂuorescent dyes: Fura Red AM (60 mM) and Fluo-4 AM (15 mM)
(Invitrogen, Grand Island, NY, USA) for 40 min and washed for
20 min immediately prior to imaging. The dyes were reconstituted
in pluronic (20% v/v in DMSO, Invitrogen, Burlington, ON) to aid
loading and decrease dye compartmentalization; sulﬁnpyrazone
(190 mM, MP Biomedicals, Lachine, QC) was added to increase
cellular dye retention. Krazy Gluewas applied to the anterior side
of the femoral shaft to ﬁx the intact femora to a glass coverslip with
condyles facing up. After the Krazy Glue had cured, the coverslip
with femur was placed inside a heated (37  1C) perfusion
chamber (Carl Zeiss Canada Ltd., Toronto, ON) and submersed in
control media. Cell viability assays ensured >90% cell viability
following the above described microdissection and in situ imaging
procedure.
200 confocal images (512  512 pixels, Olympus Fluoview
FV1000, Tokyo, Japan) of either lateral or medial condyle were
collected at 3.6 s intervals using a 40/0.8N.A. dipping objective
lens (Olympus, Tokyo, Japan) [Fig. 2(A)]. A single excitation wave-
length of 488 nm, and collection bands at 504e599 nm and 630e
730 nm were utilized. After the ﬁrst nine scans, control media was
withdrawn from the chamber and replaced by media (37  1C)Fig. 2. (A) Typical confocal image of an ex vivo wild type murine femora after incubation
ﬂuorescence, magniﬁed section of the boxed area of the overlay, depicting image resolution
type chondrocyte [Ca2þ]i ratio data of individual cells from the following treatments: (B, C)
Single [Ca2þ]i transient after 5 ng/mL TGF-b; absence of [Ca2þ]i transients from (E) 1 ng/m
arbitrary units (AU). Blue line indicates time of withdrawal and infusion of media from thecontaining IL-1, TGF-b, or the appropriate vehicle control [Fig. 2(Be
F)].
Each cell was deﬁned as a region of interest (ROI) and the
average ﬂuorescence of the two channels in each ROI was calcu-
lated using a custom MATLAB code. A signiﬁcant [Ca2þ]i transient
was deﬁned as an increase in the Fluo-4/Fura Red ratio greater than
3.5 standard deviations above the mean ﬂuctuation measured over
the ﬁrst nine control images of each ROI. Cells signaling during
these ﬁrst nine control images before withdrawal were excluded
from analysis and reported results. The percentage of cells
responding with single [Fig. 2(D)] or multiple [Fig. 2(B) and (C)]
[Ca2þ]i transients was then determined.
Quantitative real time polymerase chain reaction (qRT-PCR)
Cartilage pieces from eight wild type or integrin a1-null mice
were harvested under sterile microdissection, suspended in TRIzol
(Life Technologies, Burlington, ON) and homogenized (Tissuemiser,
Fisher Scientiﬁc, Ottawa, ON). RNAwas extracted (RNeasyMini kit,
Qiagen, Toronto, ON), quantiﬁed (Nanodrop 2000, Thermo Scien-
tiﬁc, Burlington, ON) and reverse transcribed into cDNA using oligo
dNTPs and random primers (Omniscript RT kit, Qiagen, Toronto,
ON). Primers for IL-1R1 (forward 50-CGGCGCATGTGCAGTTAATA-30,
reverse 50-TGTAGCCGTGAGGATGATAAAGC-30), IL-1R2 (forward 50-
TGCAAAGTGTTTCTGGGAACC-30, reverse 50-ATATTGCCCCCACA
ACCAAG-30), TbRI (forward 50-CTGCCATAACCGCACTGTCAC-30,
reverse 50-AAATGAAAGGGCGATCTAGTGATG-30), TbRII (forward 50-
GCAGAACACCTCAGAGCAGTTT GC-30, reverse 50-ATCCACAGACAG
AGTAGGGTCCAG-30) and GAPDH (forward 50-ACCACAGTCCAT
GCCATCACC-30, reverse 50-TCCACCACCCTGTTGCTGTA-30) were used
to measure the expression of these genes in triplicate using qRT-
PCR (CFX96 Real-Time System, Bio-rad, Mississauga, ON). mRNA
expression of each receptor was evaluated by C(t) and normalized
to the housekeeper, GAPDH.
Immunohistochemistry
Isolated femora and tibiae were ﬁxed in 4% paraformaldehyde,
decalciﬁed (CalEX, Fisher Scientiﬁc, Ottawa, ON), then submerged
in 25% sucrose. Samples were embedded in optimal cuttingwith calcium sensitive dyes; Fluo-4 (green), Fura Red (red), overlay of green and red
obtained during [Ca2þ]i experiments. Scale bars are 50 mm. (BeF) Characteristic wild
Multiple [Ca2þ]i transients after (B) 1 ng/mL IL-1 treatment or (C) 5 ng/mL TGF-b; (D)
L IL-1 vehicle control or (F) 5 ng/mL TGF-b vehicle control. Fluorescence measured in
chamber resulting in changes to ﬂuorescence due to shifting focal plane.
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were cut, washed (PBS) and blocked (normal goat serum and Triton
X (Sigma, Oakville, ON)) before sequential wash (PBS and Tween 20
(Sigma, Oakville, ON)) and antibody application. A primary anti-
body against phosphorylated Smad2 (pSmad2) (Ser465/Ser467
which also cross reacts with phosphorylated Smad3, 1:100, Cell
Signaling Technology, Danvers, MA) was applied followed by the
secondary Alexa Fluor 647 (Invitrogen, Burlington, ON) to visu-
alize pSmad2/3. The nucleic acid stain Hoescht 33342 (0.1 mM,
Invitrogen, Burlington, ON) was applied to all sections. Sections
were then mounted in ProLong Gold (Invitrogen, Burlington, ON)
and coverslipped.
Slides were imaged using an oil immersion lens (40/1.4
N.A.) on an LSM 7 DUO (Carl Zeiss Ltd., Toronto, ON) confocal
microscope in either differential interference contrast (DIC) or
channel scanning confocal modes. The Hoescht 33342 (excitation
405 nm, emission 429e684 nm) and Alexa Fluor 647 (excitation
633 nm, emission 638e755 nm) dyes were sequentially scanned
to maximize resolution. At least fourteen sections from either
the femoral condyle (244 chondrocytes) or tibial plateau (433
chondrocytes) of wild type or integrin a1-null mice were eval-
uated for the presence of pSmad2/3 by three experienced blin-
ded graders.
Statistics
Multivariate analysis of variance (ANOVA) with Fisher’s Least
Signiﬁcant Difference (LSD) post-hoc was performed on all para-
metric morphological bone and histological data using STATISTICA
software (StatSoft, Tulsa, OK). The percentage of cells responding
with [Ca2þ]i transients and the number of chondrocytes positive for
pSmad2/3 was statistically analyzed using c2 test. ANOVA with
Fisher’s LSD was performed on the [Ca2þ]i transient data using
STATISTICA software (StatSoft, Tulsa, OK). A signiﬁcance level of
P < 0.05 was used for all statistical analyses.Table I
Histology score and microCT parameters for medial and lateral femora or tibiae from kn
medial and lateral calciﬁed menisci (b). Analyzed regions of trabecular bone (red sha
illustrated in [Fig. 1(E), (F)]
Medial Lateral
Wild type a1-null Wild type a
(a) Femur
Histology
Histology score (/30) 6.11  0.51 4.11  1.02 6.00  2.31
Trabecular bone
BV (mm3  101)y,z 2.66  0.15 2.77  0.20 1.70  0.13
TV (mm3  101)y,z 4.97  0.59 5.08  0.55 4.16  0.61
BV/TV  102y,z 54.1  8.1 54.7  3.0 41.0  2.7
Conn. density 234.4  45.5 229.8  20.6 181.8  37.7 1
Tb. thickness (mm  102)y,z 8.26  1.58 7.81  0.51 6.88  0.31
Tb. space (mm  101)y,z 1.06  0.08 1.01  0.05 1.25  0.04
Tb. number 7.29  0.04 7.98  0.20 6.94  0.07
Bone den. (mg Ha/ccm) 925.3  46.9 905.7  15.7 906.8  19.0 9
App. den. (mg Ha/ccm) 551.8  71.9 544.4  28.3 453.8  22.5 4
Subchondral bone
Thickness (mm  101)y,z 1.25  0.08 1.39  0.08 1.65  0.45
TV (mm3  102) 9.68  0.53 9.68  0.59 4.94  0.68
App. den. (mg Ha/ccm)y 814.9  25.7 798.4  2.9 861.2  20.5 8
(b) Anterior meniscus
Calciﬁed menisci
TV (mm3  102)D 8.86  3.41 7.13  0.17 8.75  0.70
App. den. (mg Ha/ccm)D 713.8  14.4 671.6  22.3 795.2  6.0 8
TV ¼ Total Volume, BV ¼ Bone Volume, BV/TV ¼ Bone Volume/Total Volume, Conn. D
Histology Score usesmodiﬁedMankin Scheme.N¼ 3 independentmeasurements for each
a1-null mice (age 182 days). ‘z’ indicates femoral values signiﬁcantly different from tib
indicates anterior values signiﬁcantly different than posterior values. P < 0.05; speciﬁc PResults
Loss of integrin a1b1 does not affect knee morphology or histology
Qualitative evaluation of histological sections from the medial
and lateral condyles of wild type and integrin a1-null and knees
demonstrated similar size, abundance and organization of joint
structures, and staining distribution and intensity in all tissues
[Fig. 1(AeD)]. In particular, there were no phenotypic differences in
cartilage thickness, staining intensity, surface integrity and the size
and abundance of chondrocytes. Quantitative histological evalua-
tion conﬁrmed the absence of phenotypic differences (P ¼ 0.4607)
(Table Ia). Histological signs of very mild OAwere seen in one out of
three mice of both genotypes and included mild hypertrophy of
chondrocytes and undulating cartilage surfaces.
Qualitative comparisons of the ossiﬁed tissues of wild type and
integrin a1-null knees including trabecular bone, subchondral
bone, and calciﬁed portions of the menisci [Fig. 1(EeH)] conﬁrmed
the aforementioned similarities in joint structures and lack of
ossiﬁcation in all ligament and tendon tissues. Quantitative evalu-
ation conﬁrmed the lack of genotypic differences (P ¼ 0.9758
(trabecular bone), P ¼ 0.8320 (subchondral bone) P ¼ 0.9543
(calciﬁed menisci)), although statistically signiﬁcant site (femur/
tibia or anterior/posterior) and condyle (medial/lateral) differences
were found (Table I). Bony signs of mild OAwere seen in one out of
three mice of both genotypes and manifested as small growths of
osteophytes around patellar regions.
When both genotypes of mice were grouped, trabecular bone
volume (BV), total volume (TV), and BV/TV were greater in the fe-
mur than the tibia by 0.096 mm3 (P < 0.0001), 0.104 mm3
(P ¼ 0.0009), and 0.105 mm3 (P < 0.0001) respectively, and on the
medial compared to the lateral side by 0.026 mm3 (P ¼ 0.0123),
0.071 mm3 (P ¼ 0.0128), and 0.119 mm3 (P < 0.0001) respectively.
Tibial trabeculae were 0.010 mm thinner and 0.018 mm further
apart than those on the femur (P ¼ 0.0043, P ¼ 0.0060), and lateralees of wild type and integrin a1-null mice (a), and anterior or posterior regions of
ding), subchondral bone (blue shading) and calciﬁed menisci (green shading) are
Medial Lateral
1-null Wild type a1-null Wild type a1-null
Tibia
6.22  2.22 6.22  0.77 4.67  0.88 6.00  0.00 7.44  1.68
1.75  0.16 1.03  0.39 1.03  0.12 1.61  0.22 1.38  0.27
4.09  0.66 2.32  0.86 2.44  0.40 5.26  0.49 4.14  0.63
43.2  4.2 44.6  3.9 42.3  2.5 30.8  5.1 33.2  3.5
78.1  27.4 196.3  11.0 244.3  42.0 188.9  48.2 228.2  81.8
7.04  0.49 7.28  0.30 6.57  0.33 6.16  0.55 6.07  0.47
1.19  0.09 1.28  0.19 1.24  0.14 1.43  0.23 1.29  0.17
7.19  0.21 8.09  1.30 8.11  0.92 7.07  0.91 8.07  0.84
11.3  20.4 943.3  20.1 900.1  13.6 889.0  23.5 886.4  14.6
71.3  37.3 495.3  34.0 467.7  23.8 375.1  43.5 396.2  25.3
1.45  0.19 0.82  0.08 1.00  0.07 1.24  0.23 1.04  0.07
5.87  0.49 8.02  1.83 6.78  2.08 4.53  1.20 6.91  0.79
75.9  32.2 791.7  26.2 809.6  10.2 799.3  23.2 768.9  23.1
Posterior meniscus
9.27  0.83 1.08  0.64 1.61  0.41 1.61  0.32 2.19  0.10
20.0  33.0 691.0  25.4 668.1  18.3 648.9  30.5 683.1  9.1
ensity ¼ Connectivity Density, Tb. ¼ Trabecular, App. ¼ Apparent, Den. ¼ Density.
mean,95% conﬁdence interval. N¼ 3wild typemice (age 184 days);N¼ 3 integrin
ial values, ‘y’ indicates medial values signiﬁcantly different from lateral values, ‘D’
values in results section.
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than those on the medial side (P ¼ 0.0054, P ¼ 0.0220). The
apparent density of the femoral trabecular bone was both 16.5%
greater than that of tibial sections (P ¼ 0.0005), and 21.4% greater
on the medial compared to lateral side (P < 0.0001) (Table Ia). As
therewere no signiﬁcant differences in corresponding bone density
measurements (Table Ia), the smaller apparent density in the tibia
compared to the femur was likely attributable to increased porosity
rather than decreased density of solid bone in the tibia.
The subchondral bone was more than 4 mm thicker on the fe-
mur than the tibia (P ¼ 0.0002), and 2 mm thicker on the lateral
compared to medial side (P ¼ 0.0140). The apparent subchondral
bone density of the femur was 7.7% greater on the lateral compared
to medial side, and was 10.8% greater than the tibia on the lateral
side (P ¼ 0.0002, P < 0.0001) (Table Ia).
Interestingly, the ossiﬁed volume of the anterior menisci was
0.069 mm3 larger than the posterior menisci (P < 0.0001) and the
apparent density of the anterior portion of the calciﬁed lateral
menisci was larger than all other meniscal regions by at least
114.85 mg Ha/cm3 (16.6%) (P < 0.0001) (Table Ib). Taken together
with the observation of higher bone density in the lateral femur,
this result may indicate a preference for anterio-lateral femoral
load bearing during murine gait.
Genotype or concentration do not affect control experiment
parameters
Control experiments for IL-1 (PBS) resulted in half as many cells
responding when compared to the TGF-b controls (HCl(aq) and BSA)
(P < 0.0001) [Fig. 3(A) and (B)]. Furthermore, [Ca2þ]i transients
following PBS application were shorter and took longer to occur
compared to the HCl(aq) and BSA application in the TGF-b controls
(data not shown). Together these observations suggest that the
HCl(aq) and BSA solution increases chondrocyte sensitivity to
mobilizing [Ca2þ]i when compared to exposure to only PBS.
Importantly, neither genotype nor concentration affected the per-
centage of chondrocytes responding with [Ca2þ]i transients, nor the
analyzed [Ca2þ]i transient parameters within either IL-1 or TGF-b
control experiments. Any differences observed in [Ca2þ]i transient
numbers or properties between concentrations or genotypes re-
ported below are thus likely attributable to cytokine exposure.
Integrin a1b1 regulates [Ca2þ]i transient responses to IL-1 and TGF-b
The percentage of wild type chondrocytes responding with
[Ca2þ]i transients more than doubled when exposed to 1.0 orFig. 3. Representation of the percentage of chondrocytes responding with multiple (M) or
control (CTRL), concentration (ng/mL), and genotype (wild type or integrin a1-null (a1-null
TGF-b, and that the additional responses with treatment are largely multiple [Ca2þ]i transien
not shown) (wild type 1.0 ng/mL IL-1 P ¼ 0.0004, wild type 1.0 ng/mL TGF-b P ¼ 0.0003, w
sponding wild type stimulus (integrin a1-null 1.0 ng/mL P ¼ 0.0090, integrin a1-null 10.0
dependent femora, n  127 cells were used in each treatment.10.0 ng/mL of IL-1, in a dose independent manner [Fig. 3(A)].
Multiple signals [Fig. 2(B)] were the primary constituent of the
response [Fig. 3(A)], likely indicating the involvement of calcium
from internal stores34,35. Conversely, when integrin a1-null chon-
drocytes were exposed to the same concentrations of IL-1, the
percentage of cells signaling remained at control levels [Fig. 3(A)]
suggesting that integrin a1b1 is necessary for chondrocyte signal
transduction of IL-1 measured by [Ca2þ]i transients.
In a similar manner to IL-1, the percentage of wild type chon-
drocytes responding with an [Ca2þ]i transient almost doubled after
treatment with 1.0 or 5.0 ng/mL of TGF-b, in a dose independent
manner [Fig. 3(B)]; the majority of the additional signals were
multiple in nature [Fig. 2(C)]. In integrin a1-null chondrocytes
however, the threshold of TGF-b required to elicit a response was
tenfold lower than wild type [Fig. 3(B)], suggesting a role for
integrin a1b1 in regulating the ability of chondrocytes to sense and
respond to the presence of very low physiological levels of TGF-b3.
All concentrations at or above 0.1 ng/mL TGF-b doubled the per-
centage of integrin a1-null chondrocytes responding with [Ca2þ]i
transients [Fig. 3(B)]. Comparable to wild type cells, the majority of
responses elicited by TGF-b in integrin a1-null chondrocytes likely
involved calcium from intracellular stores as they were multiple in
nature34,35. Interestingly, genotype, concentration, or cytokine type
did not affect this multiplicity of [Ca2þ]i signaling events [Fig. 3(B)].IL-1 and TGF-b evoke different intracellular calcium transient
parameters
All [Ca2þ]i transients analyzed were symmetrical, as interpreted
by rise time being approximately half of the total duration of the
transient (data not shown). On average, treatment with either
cytokine, IL-1 or TGF-b, resulted in [Ca2þ]i transients that were 3 s
shorter compared to wild type control chondrocyte transients
(P ¼ 0.0002, data not shown). The magnitude of wild type chon-
drocyte [Ca2þ]i transients was at least 1.3 fold larger in the presence
of IL-1 or TGF-b compared to respective wild type controls
[Fig. 4(A)]. The high concentration of TGF-b (5 ng/mL) caused the
transient magnitude to increase to over 250% of the control value, a
result unique to the TGF-b stimulus [Fig. 4(A)] (P < 0.0001).
In TGF-b experiments genotype, concentration, or cytokine
presence did not inﬂuence the duration of [Ca2þ]i transients. Wild
type chondrocytes displayed a trend of increased [Ca2þ]i transient
magnitude in TGF-b treatments compared to controls [Fig. 4(B)];
transients induced by 5 ng/mL TGF-b were signiﬁcantly larger than
any other concentration [Fig. 4(B)] (P < 0.0001). In contrast, the
magnitude of [Ca2þ]i transients for controls and all concentrationssingle (S) [Ca2þ]i transients as a function of stimulant IL-1 (A), TGF-b (B), or vehicular
)). Note that integrin a1-null chondrocytes are insensitive to IL-1 but hypersensitive to
ts. ‘*’ indicates signiﬁcantly different from corresponding vehicular control (some data
ild type 5.0 ng/mL TGF-b P ¼ 0.0017). ‘#’ indicates signiﬁcantly different from corre-
ng/mL IL-1 P ¼ 0.0011) respectively. P < 0.0001 unless otherwise indicated. N ¼ 3 in-
Fig. 4. (A) [Ca2þ]i transient magnitude of wild type chondrocytes as a function of
concentration (low or high concentration that elicited a response) or treatment
(vehicle (Control) or Molecule (IL-1 or TGF-b)), measured as the change in Fluo-4/Fura
Red ﬂuorescence ratio above baseline in arbitrary units (AU). Only chondrocytes that
experienced [Ca2þ]i transients were included in the peak analysis from the afore-
mentioned treatments. Note the increase in magnitude in molecule compared to
control transients in both TGF-b and IL-1 stimulated cells, and the greater increase of
transient magnitude at the higher concentration of TGF-b but not IL-1. (B) [Ca2þ]i
transient magnitude as a function of genotype (wild type or integrin a1-null (‘a1-
null’)) in either TGF-b or corresponding vehicular control treatments. In wild type
chondrocytes, transient magnitude was larger in all concentrations when compared to
corresponding vehicular controls, in contrast to integrin a1-null chondrocytes, where
no increase of magnitude was observed. ‘*’ indicates point is signiﬁcantly different than
all other points on the same graph (P < 0.0001), ‘#’ indicates point is signiﬁcantly
different than corresponding vehicular control (Low TGF-b concentration P ¼ 0.0118,
Low IL-1 concentration P ¼ 0.0213, 1.0 ng/mL TGF-b P ¼ 0.0082). N ¼ 3 independent
femora and n  144 cells for each mean; error bars indicate 95% conﬁdence intervals.
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addition, TGF-b resulted in faster [Ca2þ]i mobilization in wild type
chondrocytes compared to vehicle controls by 28 s (P ¼ 0.0094),
and this phenomenonwas exacerbated with the loss of the integrin
a1 subunit (responses 59 s sooner than controls, P < 0.0001) (data
not shown).Fig. 5. Box and whisker plots representing normalized mRNA levels of (A) IL-1R1 and
IL-1R2 and (B) TbRI and TbRII from wild type or integrin a1-null mice. Absolute values
of mRNA were calculated for each gene of interest and normalized to GAPDH house-
keeping gene. ‘*’ indicates signiﬁcantly different from corresponding integrin a1-null
value (P < 0.01). Triplicates of three independent mRNA samples were evaluated in
each group. Each independent mRNA sample was extracted from pooled cartilage
samples harvested from eight mice.IL-1R2 expression is reduced but IL-1R1 and TbR levels are similar in
integrin a1-null chondrocytes at the mRNA level
In light of diminished [Ca2þ]i transient responses of integrin a1-
null chondrocytes to IL-1 and enhanced responses to TGF-b, we
investigated basal chondrocyte expression of the receptors IL-1R1,
IL-1R2, TbRI and TbRII associated with these responses. At the
mRNA level, expression of IL-1R2 was reduced in integrin a1-null
compared to wild type chondrocytes, however there was nodifference in expression of IL-1R1, TbRI and TbRII between the two
genotypes [Fig. 5(A) and (B)].
Enhanced pSmad2/3 levels in integrin a1-null chondrocytes
Having observed the hypersensitivity of the [Ca2þ]i transient
response of integrin a1-null chondrocytes to TGF-b treatment, but
no difference in basal TbR expression at the mRNA level, we
investigated the canonical pathway of TGF-b that requires the
phosphorylation of Smad2 and Smad3. In all sections stained by
immunohistochemistry, pSmad2/3 staining was punctate and
colocalized to both the chondrocytic cytoplasm and nucleus
[Fig. 6(AeH)]. Qualitativelymore intense stainwas found in femoral
compared to tibial chondrocytes [Fig. 6(IeP)]. More integrin a1-null
chondrocytes stained positively for pSmad2/3 compared to wild
type in both femoral (78% vs 73%) and tibial (78% vs 68%) cartilage,
reaching statistical signiﬁcance in the tibia (P < 0.0001) [Fig. 7]. In
the thicker tibial sections, the pSmad2/3 staining expanded to
include chondrocytes in the superﬁcial and deep layers of the
cartilage in addition to the middle layer that was stained in wild
type sections [Fig. 6(MeP)].
Discussion
The goal of this paper was to investigate the role of integrin
a1b1 in chondrocyte transduction of IL-1 and TGF-b. Concerning
Fig. 6. Basal phosphorylated Smad2/3 (pSmad2/3) in wild type and integrin a1-null chondrocytes. Wild type (AeD) and integrin a1-null (EeH) chondrocytes or sections of femoral
condyle (IeL) and tibial plateau (MeP) chondrocytes from wild type (I, K, M, O) and integrin a1-null (J, L, N, P) mice stained with anti-pSmad2/3 antibodies (red) (A, E, I, J, M, N),
Hoescht 33342 (blue) (B, F), overlay of both (C, G), DIC channel (D, H) and DIC channel overlaid on ﬂuorescence (K, L, O, P). Scale bar ¼ 5 mm (AeH) or 20 mm (IeP).
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or 10.0 ng/mL) double the number of chondrocytes responding
with [Ca2þ]i transients ex vivo and that integrin a1b1 is necessary
for this response3. Previous studies have shown that focaladhesions are required for IL-1 induced [Ca2þ]i signaling and that
IL-1 stimulation causes remodeling of the actin cytoskeleton in
chondrocytes, suggesting that integrins, which link the cytoskel-
eton to the extracellular matrix, may play a crucial role in
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Fig. 7. Graph of percent of basal pSmad2/3 stained chondrocytes in the femoral or
tibial cartilage from wild type or integrin a1-null mice. A larger proportion of integrin
a1-null chondrocytes (a1-null) stained positively for pSmad2/3 compared to wild type
controls, reaching statistical signiﬁcance in the tibia. ‘*’ indicates signiﬁcantly
(P < 0.001) different from corresponding wild type control. Data from a total of at least
244 femoral (n  244) and 433 tibial chondrocytes (n  433) from N ¼ 3 mice and
n  14 sections were graded in each group.
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rin a1b1 as a critical player in the mediation of chondrocyte re-
sponses to IL-1. Furthermore, we show that basal levels of IL-1R2
mRNA expression are diminished in integrin a1-null compared to
wild type chondrocytes, though no difference was found in IL-1R1
expression between the genotypes. This suggests that integrin
a1b1 can inﬂuence chondrocyte responses to IL-1 by changing
receptor expression levels, however, further investigation is
required to identify the mechanism(s) through which integrin
a1b1 exerts this inﬂuence.
The multiple nature of the [Ca2þ]i transient response to IL-1
we report points to the recruitment of internal [Ca2þ]i stores
and is in agreement with other studies, however the dose inde-
pendent nature of the response and the percentage of cells
responding in our study contrast previous ﬁndings34,35,37. Spe-
ciﬁcally, the percentage of cells responding to 10 ng/mL IL-1 with
[Ca2þ]i transient is lower than previously reported (20%
vs 91%)37. Differences in species (murine/porcine), IL-1 diffusion
(intact femora/explant) and Ca2þ sensitive dyes may have
contributed to this inconsistency41.
A key ﬁnding of this study is that physiologically relevant
concentrations of TGF-b (1 ng/mL) double the number of
ex vivo chondrocytes responding with an [Ca2þ]i transient3. The
involvement of [Ca2þ]i in enabling TGF-b mediated cell shape
change and modulation of protein kinase C dependent intra-
cellular systems has been documented in other cell types42,43.
Here we provide evidence of [Ca2þ]i involvement in TGF-b
signaling in chondrocytes, and that this involves oscillations of
[Ca2þ]i. The oscillatory nature of TGF-b induced [Ca2þ]i likely
indicates the involvement of calcium from internal stores34,35
though further investigation is necessary to identify the pre-
cise mechanism of [Ca2þ]i release. TGF-b is known to inﬂuence
collagen and glycosaminoglycan production and chondrogenic
differentiation in a dose dependent manner44,45. The increase of
[Ca2þ]i transient magnitude at higher concentrations of TGF-b
measured in our study is dose dependent, however the percentof cells signaling was not. Together these results suggest that
dose dependent TGF-b responses may arise from prolonged re-
sponses of the same cells rather than the recruitment of more
cells.
Of particular interest are our ﬁndings that integrin a1-null
chondrocytes are hypersensitive to TGF-b and also demonstrate
increased basal activation of Smad2/3 despite no differences in
basal TbR expression at the mRNA level. Together these results may
suggest that integrin a1b1 is able to regulate TbR mediated re-
sponses, however further investigation, for example measuring
pSmad2/3 expression after TGF-b treatment, may provide further
support to this hypothesis. It is known that integrin a1b1 negatively
regulates EGFR-mediated signaling by binding and activating the
tyrosine phosphatase TCPTP, thus inhibiting the dephosphorylating
EGFR25. It is possible that integrin a1b1 could regulate TbR levels
and/or activation in a similar manner, however further investiga-
tion is required to identify the speciﬁcs of this interplay.
When considered within the context of the signiﬁcant inﬂuence
of integrin a1b1 on chondrocyte transduction of both IL-1 andTGF-b,
it is remarkable that, in agreement with others, we found no signif-
icant histological and/or morphological differences between the
knees ofwild type and integrina1-nullmice at 6months of age29. It is
possible that the genotypic differences in chondrocyte responses to
IL-1 and TGF-b may only become evident at the tissue level after a
meniscal or ligamentous insult when the differences in signaling
characteristics may become vital to the initiation and progression of
osteoarthritic degradation29. In a similar vein, one might expect the
upregulation of TGF-b- and downregulation of IL-1 responses in
integrin a1-null chondrocytes to protect the integrin a1-null mouse
from osteoarthritis however this is not the case29,46e48. Integrin
a1-null mice develop spontaneous osteoarthritis earlier and more
severely than wild type controls29,46. It is possible that the height-
ened chondrocyte response toTGF-bwe reportmaycontribute to the
spontaneous osteoarthritis observed in the integrin a1-null mouse,
similar to that which occurs after multiple intra-articular injections
of TGF-b1 or the over expression of active TGF-b1 in the mouse
knee7,8,49. These studies describe ‘chondrophytes’developing in both
the cartilaginous margins of femoro-patellar and femoro-tibial joint
spaces, the collateral ligaments and the menisci 4 days post treat-
ment, a phenotype shared with spontaneous osteoarthritis in the
integrin a1-null mouse7,8,46,49. Alternatively, integrin a1b1 may in-
ﬂuence other, as of yet unidentiﬁed, degradative pathways in the
chondrocyte that override the presumed protection afforded by
heightened TGF-b and suppressed IL-1 responses measured in the
present study.
Despite the remarkable similarity at the tissue level of integrin
a1-null and wild type knees, we have shown that a1-null chon-
drocytes have heightened TGF-b mediated responses and dimin-
ished IL-1 responses as measured by [Ca2þ]i transients and the
relative activation levels of downstream Smad2/3. Together, these
results implicate integrin a1b1 in chondrocyte transduction of two
important mediators of osteoarthritis and thus the development
and progression of this disease. The speciﬁc mechanisms by which
integrin a1b1 modulates these signaling pathways currently
remain unknown.
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